U.S. Physical Therapy reported a 10.8% increase in total revenue to $140.7 million for the second quarter of 2022, driven by growth in physical therapy operations and industrial injury prevention services. However, net income attributable to USPH shareholders decreased to $11.2 million, and operating income also saw a decrease.
Operating Results per diluted share was $0.90, the second highest quarterly amount in the Company’s history.
Adjusted EBITDA was $21.3 million.
Net income attributable to shareholders was $11.2 million.
Total revenue was $140.7 million, an increase of 10.8%.
Management expects Adjusted EBITDA for the full year of 2022 to be in the range of $73.5 million to $75.4 million and Operating Results to be in the range of $2.65 to $2.75 per share.
Analyze how earnings announcements historically affect stock price performance